• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Hikma says "low likelihood" of US approval this year for Advair generic firstwordpharma
    May 12, 2017
    Hikma Pharmaceuticals announced Thursday that the FDA issued a complete response letter regarding the company's filing seeking approval of a generic version of GlaxoSmithKline's asthma and chronic obstructive pulmonary disease therapy Advair Diskus (fluti

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service